Nanobiotix (NASDAQ:NBTX) Stock Price Up 3.6% – Here’s What Happened

Nanobiotix S.A. (NASDAQ:NBTXGet Free Report)’s stock price rose 3.6% on Tuesday . The company traded as high as $4.36 and last traded at $4.36. Approximately 10,235 shares changed hands during trading, a decline of 42% from the average daily volume of 17,666 shares. The stock had previously closed at $4.21.

Wall Street Analyst Weigh In

Separately, Guggenheim began coverage on shares of Nanobiotix in a research report on Wednesday, August 28th. They set a “buy” rating and a $12.00 price target on the stock.

Check Out Our Latest Research Report on NBTX

Nanobiotix Stock Performance

The firm’s 50-day moving average is $4.98 and its 200-day moving average is $5.42.

Nanobiotix Company Profile

(Get Free Report)

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.

See Also

Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.